VANTAGE 095: An International, Multicenter, Open-Label Study of Vorinostat (MK-0683) in Combination With Bortezomib in Patients With Relapsed and Refractory Multiple Myeloma
Titel:
VANTAGE 095: An International, Multicenter, Open-Label Study of Vorinostat (MK-0683) in Combination With Bortezomib in Patients With Relapsed and Refractory Multiple Myeloma
Auteur:
Siegel, David S. Dimopoulos, Meletios Jagannath, Sundar Goldschmidt, Hartmut Durrant, Simon Kaufman, Jonathan L. Leleu, Xavier Nagler, Arnon Offner, Fritz Graef, Thorsten Eid, Joseph E. Houp, Jennifer Gause, Christine Vuocolo, Scott Anderson, Kenneth C.